Zoetis Inc., A Leading Animal Health Company, Announced That The Us Food And Drug Administration (Fda) Has Approved Solensia To Control The Pain Of Osteoarthritis (Oa) In Cats, Helping Improve Their Mobility, Comfort And Overall Well-Being. As A Once-Monthly Injection Administered In The Veterinary Clinic, Solensia Keeps Oa Pain From Disrupting The Unique Bond Cats Share With Their Humans.Feline Oa, A Highly Prevalent Condition With Nearly 40% Of All Cats Showing Signs Of Oa Pain, Occurs When The Protective Tissue In The Joints (Cartilage) Is Worn Down, Causing Bones To Rub Together. This Makes Moving Harder And Causes Severe Pain. Without Treatment, Oa Pain Can Worsen Over Time And Seriously Affect A Cat
